We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTA
6051
PUT
DELISTED
Avantax, Inc. Common Stock
AVTA
$44K ﹤0.01%
1,100
-400
-27% -$14.6K
ONCE
6052
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$44K ﹤0.01%
+800
New +$54.7K
PFSW
6053
DELISTED
PFSweb, Inc.
PFSW
$44K ﹤0.01%
5,913
+3,931
+198% +$35.4K
CCB icon
6054
Coastal Financial
CCB
$743M
$43K ﹤0.01%
+2,499
New +$41.3K
CRD.B icon
6055
Crawford & Co Class B
CRD.B
$588M
$43K ﹤0.01%
4,674
+3,818
+446% +$33.3K
FLO icon
6056
CALL
Flowers Foods
FLO
$1.51B
$43K ﹤0.01%
2,300
-4,400
-66% -$88.8K
GWRS icon
6057
Global Water Resources
GWRS
$212M
$43K ﹤0.01%
4,052
+3,328
+460% +$32.7K
KPTI icon
6058
CALL
Karyopharm Therapeutics
KPTI
$44.4M
$43K ﹤0.01%
+167
New +$46.2K
NUAN
6059
PUT
DELISTED
Nuance Communications, Inc.
NUAN
$43K ﹤0.01%
2,888
+231
+9% +$3.2K
HDS
6060
PUT
DELISTED
HD Supply Holdings, Inc.
HDS
$43K ﹤0.01%
+1,000
New +$43.8K
FOMX
6061
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$43K ﹤0.01%
7,466
-13,180
-64% -$75.4K
KERX
6062
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$43K ﹤0.01%
12,600
+1,900
+18% +$6.85K
ASH icon
6063
CALL
Ashland
ASH
$3.45B
$42K ﹤0.01%
500
-5,500
-92% -$459K
FBIN icon
6064
CALL
Fortune Brands Innovations
FBIN
$5.73B
$42K ﹤0.01%
936
-1,287
-58% -$60.5K
GENC icon
6065
Gencor Industries
GENC
$235M
$42K ﹤0.01%
3,440
+2,796
+434% +$38.4K
IBRX icon
6066
ImmunityBio
IBRX
$7.94B
$42K ﹤0.01%
11,440
+9,332
+443% +$29.5K
ITOT icon
6067
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$42K ﹤0.01%
630
GHL
6068
PUT
DELISTED
Greenhill & Co., Inc.
GHL
$42K ﹤0.01%
+1,600
New +$47.5K
OBSV
6069
DELISTED
ObsEva SA Ordinary Shares
OBSV
$42K ﹤0.01%
2,347
+1,847
+369% +$27.1K
NWHM
6070
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$42K ﹤0.01%
5,221
+4,274
+451% +$39.1K
AVP
6071
CALL
DELISTED
Avon Products, Inc.
AVP
$42K ﹤0.01%
19,000
-13,400
-41% -$24.7K
SXCP
6072
DELISTED
SunCoke Energy Partners, L.P.
SXCP
$42K ﹤0.01%
+2,740
New +$43.2K
EMES
6073
CALL
DELISTED
Emerge Energy Services LP
EMES
$42K ﹤0.01%
10,500
+5,900
+128% +$35K
AEG icon
6074
Aegon
AEG
$14B
$41K ﹤0.01%
7,398
-7,694
-51% -$40K
BOTZ icon
6075
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.55B
$41K ﹤0.01%
1,786

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.